Immunotherapy Drugs Market Size, Share, Growth Report 2030

The report covers a forecast and an analysis of the immunotherapy drugs market on a global and regional level. The study provides historical data from 2016, 2017, and 2018 along with a forecast from 2019 to 2025 based on revenue (USD Billion). The study includes drivers and restraints for the immunotherapy drugs market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the immunotherapy drugs market on a global and regional level.

In order to give the users of this report a comprehensive view of the immunotherapy drugs market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

Request Free Sample

The report provides company market share analysis to give a broader overview of the key market players. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the immunotherapy drugs market on a global and regional basis.

The study provides a decisive view of the immunotherapy drugs market by segmenting the market based on drug type, therapeutic applications, end-user, and region. By drug type, the market is segmented into adult vaccines, monoclonal antibodies, checkpoint inhibitors, interleukins, interferon alpha and beta, and others. Preventive vaccines and therapeutic vaccines comprise the adult vaccines segment. By therapeutic application, this global market is segmented into autoimmune and inflammatory diseases, cancer, infectious diseases, and others. Cancer segment is further divided into the solid tumor and malignant. Hospitals, clinics, and others form the end-user segment of the global immunotherapy drugs market.

The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further divided into major countries including the U.S. Canada, Germany, France, the UK, China, Japan, India, and Brazil.

Some key players of the immunotherapy drugs market include F. Hoffmann-La Roche AG, Amgen, Inc., Novartis International AG, AbbVie, Inc., Merck & Co., Inc., GlaxoSmithKline, Eli Lilly and Company, Bristol-Myers Squibb, AstraZeneca plc, and Johnson & Johnson, among others.

This report segments the global immunotherapy drugs market into:

Global Immunotherapy Drugs Market: By Drug Type

• Monoclonal Antibodies
• Adult Vaccines
  • Preventive Vaccines
  • Therapeutic Vaccines
• Checkpoint Inhibitors
• Interferons Alpha and Beta
• Interleukins
• Others

Global Immunotherapy Drugs Market: By Therapeutic Application

• Cancer
  • Solid Tumor
  • Malignant
• Autoimmune and Inflammatory Diseases
• Infectious Diseases
• Others

Global Immunotherapy drugs Market: By End-User

• Hospitals
• Clinics
• Others

Global Immunotherapy Drugs Market: By Region

• North America
  • The U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• Middle East and Africa